Magnesium Stress Randomized Trial: What the Evidence Says

Quick Answer

Magnesium Stress Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• , Over 3.5 million people around the world with kidney failure rely on regular hemodialysis sessions for their survival.Unfortunately, cardiovascular disease (CVD) accounts for nearly half of their deaths, with cardiovascular mortality rates 10 to 20 times higher than the general population.Effective interventions are urgently needed to reduce this risk. [Tannar Bryn (2026); evidence level 4]
• , 16 24, 16 Magnesium supplementation, either orally or by raising the concentration of dialysate magnesium, is considered safe in hemodialysis patients and has been associated with improved surrogate indicators of cardiovascular health. [Tannar Bryn (2026); evidence level 4]
• Epidemiological data consistently demonstrate that low dietary Mg intake and low serum Mg are independently associated with hypertension, coronary artery calcification, peripheral arterial disease (PAD), stroke, and cardiovascular mortality. [Yoon Yonghyun (2026); evidence level 4]
• Based on these criteria and the conceptual scope of this narrative review, the most relevant mechanistic, translational, epidemiological, clinical, guideline, and nutritional reference sources were incorporated into the final narrative synthesis. [Yoon Yonghyun (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For magnesium stress randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Tannar Bryn (2026). Effects of Increasing the Concentration of Dialysate Magnesium on Cardiovascular Health: A Narrative Review. DOI: 10.1177/20543581261454463. PMCID: PMC13254138. PMID: 42293164. License: https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ https://us.sagepub.co.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13254138/
• Yoon Yonghyun (2026). Magnesium at the Neurovascular Interface: A Narrative Review of Atherosclerosis, Peripheral Arterial Disease, and Neuropathic Pain. DOI: 10.3390/nu18111675. PMCID: PMC13257608. PMID: 42280320. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13257608/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.